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Abstract
Background: Inflammatory cascades contribute to secondary injury after intracerebral hemorrhage (ICH) via
humoral factors and cell-mediated cytotoxicity. Several experimental models were previously developed to analyze
post-hemorrhagic neuroinflammation. However, neuroinflammatory markers have not been compared face-to-face
between these models so far, and therefore, pathophysiological conclusions drawn from only one individual model
may not be valid.
Methods: We compared neuroinflammatory pathways in the two most common murine models: striatal injection
of autologous blood or collagenase. Expression of pro- and anti-inflammatory cytokines (IL-1, TNF-a, IFN-g, IL-6,
TGF-b and IL-10) as well adhesion molecule expression (VCAM-1, ICAM-1) was analyzed by RT-PCR at several time
points after ICH induction. Outcome and physiological parameters were compared between the models.
Results: Both models induced a profound and dynamic increase in the expression of pro-inflammatory cytokines
and adhesion molecules. However, blood injection resulted in significantly more pronounced alteration of these
markers than collagenase injection. This difference was associated with worse outcome after blood injection
compared to the collagenase model despite equal ICH volumes.
Conclusions: This is the first study performing a face-to-face comparison of neuroinflammatory pathways in the
two most widely used murine ICH models, revealing substantial differences between the models. This discrepancies
need to be taken into account in designing future studies employing experimental ICH models, especially when
analyzing neuroinflammatory pathways and therapies.
Background
Intracerebral hemorrhage (ICH) represents about 10-
15% of all strokes. Compared to ischemic stroke, it is
associated with substantially higher morbidity and mor-
tality [1,2]. In contrast to the major importance of ICH
as a health care problem, no specific therapy for ICH is
available until now. Moreover, the current understand-
ing of crucial pathophysiological mechanisms is limited
[3].
To improve the search for potential therapeutic tar-
gets in ICH, several rodent models of ICH have been
developed [4-6]. The most widely used techniques are
direct injection of either blood or of collagenase, respec-
tively [4,7,8]. Collagenase digests the extracellular matrix
of small vessels and dose-dependently causes blood
extravasation. Although both methods fail to reflect
important components of the pathophysiology of ICH in
patients [9], they allow to study the impact of extravas-
cular blood on the brain parenchyma. However, differ-
ences in signaling cascades of pathophysiologically
relevant mechanisms between these models are likely.
Secondary inflammatory damage to brain tissue has
emerged as a common link between differing types of
central nervous system disorders [3,10-12]. Several stu-
dies using rodent ICH models have suggested a signifi-
cant contribution of inflammatory pathways to the
pathophysiology of ICH [13,14]. Inflammatory mechan-
isms have been examined in both the blood and the col-
lagenase injection model [13]. The main inflammatory
* Correspondence: Arthur.Liesz@med.uni-heidelberg.de
† Contributed equally
1Department of Neurology, University Heidelberg, Im Neuenheimer Feld 400,
69120 Heidelberg, Germany
Full list of author information is available at the end of the article
Liesz et al. Experimental & Translational Stroke Medicine 2011, 3:11
http://www.etsmjournal.com/content/3/1/11
© 2011 Liesz et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.pathways after ICH are leukocyte migration into the
brain, microglial activation, cerebral cytokine expression
and production of other neurotoxic factors including
matrix metalloproteinases and reactive oxygen species
[14]. Unfortunately, specific aspects of neuroinflamma-
tion have not been compared face-to-face between these
models so far, and therefore, pathophysiological conclu-
sions drawn from only one individual model may not be
valid.
The aim of the present study therefore was to com-
pare the dynamic changes in cerebral expression of
important cytokines and adhesion molecules as key mar-
kers of neuroinflammation in the autologous blood
injection and the collagenase injection model of intra-
cerebral hemorrhage.
Materials and methods
Animals
In accordance with national guidelines for the use of
experimental animals the study was conducted using
age-matched, mature male mice (C57BL/6, Charles
River Laboratories, 10-12 weeks of age, body weight
20-25 g). The protocols were approved by the govern-
mental committees (Regierungspraesidium Karlsruhe,
Germany).
Animal experiments
Spontaneously breathing mice were anesthetized with
halothane (1%-1.5%) in an oxygen/air mixture. After pla-
cing the animals in a stereotactic frame (Stoelting, USA)
with a mouse adaptor (Model 51625, Stoelting, USA) a
borehole was drilled at 2 mm left and 0.5 mm anterior
to the bregma as previously described [15,16].
Using an infusion system containing a 25 G needle
connected (1) to a 50 μl microsyringe (Hamilton, Swit-
zerland) for the injection of 30 μL autologous blood
(taken from the retro-orbital plexus) or (2) to a 10 μL
microsyringe (SGE, Austria) for the injection of 0.5 μL
sterile saline containing 0.045 U collagenase type VII
(Sigma, Germany) was inserted into the striatum at 3.5
mm depth from scull. The duration of both operations
of approximately 45 min was matched to avoid an inter-
ference caused by perioperative management including
anesthesia. Sham operation was conducted by the same
procedure and with the same duration as for ICH
induction including placement of the microneedle but
without injection of fluid.
Hematoma measurement
In separate experiments, mice were euthanized 24 h
after ICH induction (n = 7 per group). 40 μm thick cor-
onal cryosections were cut every 400 μm. Unstained sec-
tions were scanned at 600 dpi. The hemorrhagic area
was marked and measured using a public domain image
analysis program (ImageJ). Total hematoma volume was
obtained by integrating measured areas and distance
between sections.
RNA isolation and real-time polymerase chain reaction
RNA was isolated from separated cerebral hemispheres
using the RNeasy kit (Qiagen). Reverse transcription was
performed with the High Capacity complementary DNA
Archive Kit and real-time polymerase chain reaction with
SYBR-Green assays (on an ABI7500 real-time polymerase
chain reaction system (Applied Biosystems). Primers
were purchased as ready-to-use primer sets for each gene
(all from Super Array, IL-1b: PPM03109E, IL-10:
PPM03017B, IL-6: PPM03015A, TNF-a: PPM03113A,
IFN-g: PPM03121A, TGF-b: PPM02991A, VCAM-1:
PPM03208B, ICAM-1: PPM03196A). All assays were run
in duplicates. A linear dilution-amplification curve was
obtained from diluted pooled samples. Using this curve
the expression of each gene was quantified relative to the
expression of the housekeeping gene encoding for pepti-
dylprolyl isomerase A (cyclophilin), according to the rela-
tive standard curve method. Analysis of mRNA
expression was performed blinded to treatment groups.
Statistical analysis
All values in bar graphs are expressed as mean ± stan-
dard deviation (SD). We used the Mann-Whitney U-
Test for comparison of two groups. For three or more
groups we applied the Kruskal-Wallis H test with
Dunn’s post hoc testing, using GraphPad Prism 5 soft-
ware. P < 0.05 was considered statistically significant.
Results
Differing outcome despite same ICH volume in the
autologous blood and colleganase injection model
Both models were optimized to induce ICH of compar-
able blood volume as used in most previous experimen-
tal ICH studies [15-17]. Injection of either 30 μL
autologous blood or 0.045 U collagenase VII into the
left striatum resulted in an intracerebral hematoma
volume of approx. 15-17 mm
3 (Figure 1a, b). However,
24 h after ICH induction the hemorrhagic area appeared
generally denser in the blood injection model than after
collagenase-induced ICH (Figure 1a). Total mortality of
mice differed between the experimental models in this
s t u d y( F i g u r e1 c ) .W h i l en om i c ed i e di nt h es h a m
group, overall mortality was 6.3% in the collagenase
injection model (3/48 operated mice) and 10.1% in the
autologous blood injection model (8/79 operated mice).
Both ICH models were associated with a pronounced
weight loss compared to sham operated mice (Figure
1d). However, only mice undergoing blood-injection
I C Hs h o w e das i g n i f i c a n tb u tt r a n s i e n th y p o t h e r m i a2 4
h after ICH compared to the sham group (Figure 1d).
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cytokines
We analyzed the relative expression of key pro-inflam-
matory cytokines at 3 h, 24 h, 72 h and 7d after ICH
induction in both ICH models and after sham opera-
tion (Figure 2). IL-1b and TNF-a have been well char-
acterized as the main neurotoxic cytokines of
microglial source after ischemic and traumatic brain
injury [18-20]. We detected a significant increase of
both cytokines in the hemorrhagic hemispheres of
mice undergoing ICH induction in both models com-
pared to the sham group (Figure 2a, b). Increased cyto-
kine expression occurred very early after ICH and
peaked already at 3 h for TNF-a a n da t2 4hf o rI L -
Figure 1 Characterization of the used ICH models. (a) Representative images from the same anatomical region at 24 h after sham operation,
intrastriatal injection of 0.045 U collagenase ("Collagenase”)o r3 0μl autologous blood ("Blood”) as used for measurement of hematoma volume.
(b) Hemorrhage volume was determined 24 h after ICH by integration of serial coronal sections, no difference between the collagenase and
blood injection model was detected (n = 7, 2 individual experiments). (c) Overall mortality was determined for all animals used in this study
treated by sham operation or ICH induction by one of both models, respectively. (d) Body weight and rectal body temperature was measured in
naïve mice and at the indicated time points after sham operation or ICH induction by the respective model (n = 6-11 per group).* p < 0.05
between Sham and Collagenase; # p < 0.05 between Sham and Blood.
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injection, induced a significant increase in IL-1b at 24
ha n dT N F - a expression 3 h after ICH in the contral-
ateral, non-hemorrhagic hemisphere (Figure 2a, b). IL-
6 is a pleiotropic cytokine produced by various cellular
sources in the brain after CNS lesions [21]. IL-6
expression was significantly increased 6 h after ICH in
both ICH models and at 24 h in the collagenase model
Figure 2 Expression patterns of pro-inflammatory cytokines after ICH. Relative expression (RE) was determined for (a) IL-1b,( b )T N F - a,( c )
IL-6 and (d) IFN-g at the indicated time points in the hemorrhagic (ipsilateral) and non-hemorrhagic (contralateral) hemispheres after sham
operation or ICH induction by the collagenase or autologous blood injection model. Horizontal lines indicate significant statistical differences (p
< 0.05) between the indicated groups (n = 5 per group, 2-3 individual experiments).
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gous blood injection resulted in significantly higher IL-
6 expression than collagenase injection in the hemor-
rhagic and the non-hemorrhagic hemisphere at 6 h
(Figure 2c). Interferon-gamma (IFN-g) was analyzed as
the key neurotoxic cytokine produced by activated
lymphocytes [22,23]. IFN-g expression did not increase
within the first 3d after ICH, but was significantly
overexpressed 7d after ICH in both ICH models com-
pared to sham (Figure 2d). Blood injection induced a
significantly higher, approx. 5-fold IFN-g expression
compared to the collagenase-injection model and also
increased IFN-g expression in the contralateral hemi-
sphere (Figure 2d).
Cerebral expression patterns of anti-inflammatory
cytokines
Previous reports from our and other groups have
shown a neuroprotective effect of the anti-inflamma-
tory cytokines IL-10 and TGF-b, respectively, after
CNS lesions [20,24-26]. We detected a significant
increase of IL-10 mRNA expression only in the autolo-
gous blood injection model (Figure 3a). An up to 3-
fold increase in IL-10 expression occurred in the
hemorrhagic hemispheres 24 h to 7d after striatal
blood injection, while collagenase-induced ICH did not
affect IL-10 expression (Figure 3a). In contrast, TGF-b
transcription was not altered by any experimental pro-
tocol at any time point after ICH induction or sham
operation (Figure 3b).
Expression of cerebral adhesion molecules after
experimental ICH
The endothelial adhesion molecules VCAM-1 and
ICAM-1 have been associated with transendothelial dia-
pedesis of leukocytes and subsequent secondary neu-
roinflammation in various non-inflammatory CNS
disorders and particularly experimental ischemic stroke
[27-29]. Significant VCAM-1 upregulation was observed
only in the hemorrhagic hemispheres in the autologous
Figure 3 Expression patterns of anti-inflammatory cytokines after ICH. We determined the relative expression (RE) of (a) IL-10 and (b) TGF-b
mRNA at the indicated time points in the hemorrhagic (ipsilateral) and non-hemorrhagic (contralateral) hemispheres after sham operation or ICH
induction by the collagenase or autologous blood injection model. Horizontal lines indicate significant statistical differences (p < 0.05) between
the indicated groups (n = 5 per group, 2-3 individual experiments).
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sham and collagenase injection (Figure 4a). Surprisingly,
collagenase injection did not significantly alter VCAM-1
expression at any measured time point after ICH induc-
tion (Figure 4a). In contrast, ICAM-1 expression was
already substantially increased 3 h after ICH induction
in both models compared to sham control (Figure 4b).
ICAM-1 expression was approx. 12-fold higher than in
sham treated animals already 3 h after ICH in the blood
injection model and was also significantly higher than in
the collagenase group (Figure 4b). A similar pattern, but
less pronounced, was observed 24 h after ICH. In con-
trast, at 3d and 7d after hemorrhage ICAM-1 expression
was already normalized again in the collagenase injec-
tion model while it remained significantly upregulated
in animals with blood-injection ICH.
Discussion
To the best of our knowledge, this is the first study per-
forming a face-to-face comparison of neuroinflammatory
pathways in the two most widely used models of murine
experimental intracerebral hemorrhage. The major find-
ings of this work are that (1) experimental ICH induces
a profound induction of cerebral cytokine expression,
(2) ICH increases the expression of cerebral adhesion
molecules, (3) autologous blood injection alters these
mechanisms generally more pronounced than collage-
nase injection, (4) blood injection, but not collagenase,
induces neuroinflammatory pathways also in the con-
tralateral hemispheres, and (5) the difference in the
extent of ICH-induced neuroinflammation between the
2 models is associated with worse outcome in the blood
than the collagenase injection model despite equal
hematoma volumes.
The kinetics of cytokine expression within the first
week after experimental ICH was quite dynamic. The
expression pattern differed distinctively between the
analyzed cytokines and showed an early peak for IL-1,
TNF-a and IL-6 while IFN-g was significantly increased
only at 7d after ICH. The kinetics of cerebral cytokine
Figure 4 Expression of cerebral endothelial adhesion molecules after ICH. (a) VCAM-1 and (b) ICAM-1 expression was measured at the
indicated time points in the hemorrhagic (ipsilateral) and non-hemorrhagic (contralateral) hemispheres after sham operation or ICH induction by
the collagenase or autologous blood injection model. Horizontal lines indicate significant statistical differences (p < 0.05) between the indicated
groups (n = 5 per group, 2-3 individual experiments).
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observed after focal cerebral ischemia [30,31]. There,
microglial cells have been identified as the main produ-
cers of the early increase in intracerebral IL-1 and TNF-
a, while the delayed expression of IFN-g correlated with
the later invasion of lymphocytes-the main source of
IFN-g-to the brain [20,32-34]. VCAM-1 mRNA expres-
sion also showed a delayed increase in parallel to IFN-g
expression. This is especially notable because VCAM-1
has previously been shown to be the key adhesion mole-
cule controlling invasion of lymphocytes to brain lesions
after ischemic stroke [23,28] and might thereby be of
relevance in the cascade of lymphocyte invasion and
cerebral IFN-g production after ICH.
Previous studies have investigated microglia/macro-
phage activation as well as brain leukocyte invasion after
experimental ICH [34-36]. Neutrophils have been shown
as the earliest subpopulation invading the brain after
ICH in preclinical studies [37]. Moreover, lymphocytes
migrated to the lesion at approx. 48-72 h after ICH [35].
A report by Loftspring et al. using FACS analyses of
brain homogenates after blood injection has documen-
ted an early influx of granulocytes and a delayed inva-
sion of CD4+ and CD8+ T cells [34]. Xue and Del Bigio
[36] compared the cellular immune reactions in 3 ICH
rodent models, including autologous blood injection and
collagenase injection. Interestingly, this study detected
distinct differences in the kinetics and magnitude of
neutrophile and CD8+ lymphocyte brain influx and
microglial activation between the blood and the collage-
nase injection model in rats as blood injection resulted
in earlier microglial activation and CD8+ T cell migra-
tion to the brain compared to collagenase-induced ICH.
We detected in this study profound differences in
neuroinflammatory pathways between the two most
common murine ICH models independent of ICH
volume. In general, the autologous blood injection
model induced more pronounced alterations in the ana-
lyzed immunological pathways in the hemorrhagic hemi-
sphere-pro-inflammatory cytokines, anti-inflammatory
cytokines and adhesion molecule expression-compared
to the collagenase model. Additionally, only ICH induc-
tion by the autologous blood injection model (except for
IL-6 expression at 3 h) induced significantly the expres-
sion of cytokines and adhesion molecules also in the
contralateral, non-hemorrhagic hemisphere. Previous
reports analyzing intracerebral cytokine expression in
murine ICH models have used either autologous blood
injection [38,39] or collagenase-induced ICH [40,41].
There, both models resulted in increased pro- and anti-
inflammatory cytokine expression. However, the present
study shows substantial differences in cytokine expres-
sion between ICH models.
Previous reports have documented an increase in cere-
bral ICAM-1 expression after ICH in the blood injection
model [39,42,43]. We could reproduce these findings
and detected additionally ICAM-1 induction in the col-
lagenase model which was weaker compared to blood
injection. VCAM-1 has been proposed as a therapeutic
target in ischemic stroke and traumatic brain injury
[23,44]. This is the first study to characterize VCAM-1
expression after ICH. Surprisingly, we observed a signifi-
cant increase in VCAM-1 expression in the blood injec-
tion but not the collagenase injection model. The
relevance of this major discrepancy between the two
ICH models on leukocyte invasion, neuroinflammation
and outcome needs to be further investigated because of
the key role of VCAM-1 in the inflammatory cascade
after brain injury [28].
Developing new therapies for ICH is the ultimate goal
of translational stroke research. So far more than 30 stu-
dies have investigated anti-inflammatory therapies tar-
geting various cells and molecules in animal models of
ICH [14,45]. Experiments in these studies were per-
formed in different species, used different methods to
induce ICH, and produced different hematoma volumes
in relation to the volume of the affected hemisphere. As
long as the inflammatory cascades participating in the
pathophysiology of human ICH are largely unknown,
translational experiments have to take potential discre-
pancies of experimental models into account and should
test hypotheses in different models.
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